Company funding profiles

Follow the money

Funding histories for healthcare companies, read against their SEC Form D filings: what was announced, what was filed, who sits on the board, and which investment vehicles were formed around them.

• 10x10x reports $500K raised through trackers, but no SEC Form D exists under its name or its prior name, GradeWiz. Here is what the record shows.
• 1910 GeneticsA single 2021 Form D shows $25.7 million sold to 19 investors. The 2024 Accenture Ventures investment has no matching SEC filing to size it.
• 20nNo Form D was ever filed for 20n Labs. What the DARPA contracts, the abandoned patents and the conflicting raise figures actually show.
• 54geneTwo Form D filings, a Series A that sold more than it announced, and a Series B offering never amended. What 54gene's SEC record actually shows.
• 64x BioTwo disclosed rounds totalling $59.5 million, the last closed in January 2022, and nothing at the SEC under 64x Bio or 64-X, Inc.
• 7 Cups7 Cups has filed no Form D in 13 years. Reported seed totals range from 96,000 dollars to 18 million, and its largest inflow was a state contract.
• Abalone BioEight years, $7.45M of NIH and NSF grants, a single $165,375 Form D from an outside vehicle, and no priced venture round on the public record.
• Able HealthOne Form D, a $27 million announced price, $21.5 million booked as consideration, and an earnout that settled at about a fifth of its cap.
• Actipulse NeuroscienceActipulse raised $201,600 of a $1,070,000 Regulation CF offering in 2021, then terminated SEC reporting in April 2023. What the filings actually show.
• Adaptyv BioAdaptyv Bio has announced about $50.5 million since 2022 with no Form D on record. What the 2021 Form C and the Swiss register actually show.
• AdentrisAdentris says it raised $1.8 million in a 2025 pre-seed round, but no Form D appears in SEC EDGAR and aggregators disagree on the total raised.
• AdialanteAdialante has raised NSF SBIR grants and a YC investment. No Form D is on record for its targeted seed round or its signed clinic letters of intent.
• AdniAdni raised about 1.5 million dollars through Y Combinator in 2021 and 2022. No SEC Form D has been found, and its backer list has since grown.
• AdravisionA Singapore dental AI startup with no SEC filing found, a Y Combinator check, and a 2024 accelerator SAFE tied to a move to Atlanta.
• Adventris PharmaceuticalsThree peer reviewed phase 1 papers, one $500K round on the public record and zero SEC filings. What the Adventris capital trail does and does not show
• adynOne reported seed round in 2021, zero Form D notices at the SEC, and five years with no disclosed financing. The adyn capital record, read closely.
• AegisSEC records show a small investor SPV, not a company Form D. What is confirmed about Aegis funding, and what remains unverified reporting.
• AesculaTechAesculaTech has never filed a Form D. Trackers show $120K of disclosed private capital against $1,471,170 in National Eye Institute SBIR awards.
• AgapéA single 2021 SEC filing shows 14 investors and $1.77 million sold for Rochester relationship app Agapé, with no capital raise on record since.
• AgileMDAgileMD has $2.75M in NIH and BARDA money on record, $2.5M in reported private capital and no Form D on file with the SEC. What that means.
• AidyAidy has one reported seed round from Y Combinator and no Form D on EDGAR. Here is what the funding record for this IBD app actually shows.
• AIOSNo SEC Form D exists for AIOS Medical or Fella Health. Seed estimates range from 75,000 to 130,000 dollars, and three EDGAR mentions are unrelated Tok
• AkidoAkido announced a $60M Series B. The Form D filed the next day reports $84,254,689 sold to 94 investors, plus two single-company SPVs.
• Akute HealthAkute Health has one disclosed funding figure, a $125,000 Y Combinator check, and no Form D filed with the SEC. Here is what the record shows.
• AlemHealthAlemHealth raised between $85,000 and $356,000 depending on the data provider. No SEC Form D exists. Here is what the Singapore register shows.
• AlfieAlfie raised a $2.1 million pre-seed round in 2023 and was acquired by knownwell in 2024 for an undisclosed price, with no SEC Form D found.
• Algen BiotechnologiesEight years, $11 million of reported equity, one NIH grant and zero SEC filings behind a $555 million AstraZeneca partnership announced in October 202
• AlixiaAlixia sold $1.83M of a $3.47M offering to 19 investors in 2024. What the SEC filings show, and where the databases disagree with them.
• Allotrope MedicalTwo Form D filings six weeks apart show $5.05M sold from 90 investors, more than the $4M Series A the company announced. Plus $1.18M from NSF.
• Almond ObGynA single SEC Form D shows Almond Life, Inc. sold $7.2 million to 42 investors in 2022. The company closed its clinic in March 2026.
• Altay TherapeuticsFive SBIR Phase I awards worth $1.57M, a $3M SOLVE FSHD investment, zero Phase II dollars and no Form D on file with the SEC as of September 2026.
• Amby HealthTrackers put Amby Health's funding between $50,000 and $500,000, and no SEC Form D exists under its own name. Here is what the filings and reports act
• AminoAnalyticaAminoAnalytica's UK company was struck off within five months of forming. No SEC Form D was found. Figures come only from business aggregators.
• AmulyteWhat is known about Amulyte's capital: a reported $250,000 seed, a $2 million crowdfunding target, and no SEC Form D found on record.
• Ananya HealthTwo Form D filings cover $404,000 of SAFEs while NCI awards total $2.69 million. What the Ananya Health filings show, with the arithmetic.
• Andromeda SurgicalThree SPVs sold $536,951 to back Andromeda Surgical, while the company itself has never filed a Form D. What the SEC record shows about a $30M raise.
• Andson BiotechTwo Form D filings, $8,335,000 of equity sold to 66 investor slots, and $1.71M of NIH SBIR awards. The arithmetic behind Andson Biotech's raises.
• Andy AIA reported $500,000 pre-seed and a small SEC Form D for an investor vehicle are the only funding records found for Andy AI as of September 2026.
• Angstrom AINo SEC Form D found for Angstrom AI. Aggregators report conflicting seed figures while a UK holding company shows two directors departing.
• AnimaAnima's Form D shows $14.49 million sold, more than the $12 million Series A it announced. A second 2025 SPV points to unannounced activity.
• Anja HealthAnja Health raised $4.9 million, reached profitability on $1.5 million of storage revenue and sold in 2026. No SEC filing records any of it.
• Ankr HealthWhat SEC EDGAR and private data providers show, and do not show, about Ankr Health's 2022 seed round and its funding since then.
• Ansa BiotechnologiesFour Regulation D offerings record $124.2 million sold. The Series B was announced at $54.4 million and filed at $45.2 million. Here is the arithmetic
• AnthrogenAnthrogen reported a $4 million seed round in 2024. No SEC Form D has surfaced since, and the business it funded has changed. Here is the record.
• Anto BiosciencesWhat the public record shows about Anto Biosciences' seed round, its named investors, and the absence of a matching SEC Form D filing so far.
• AOA DxFive Form D notices report $38.7 million sold since 2021, against a company-stated $24 million total. What the SEC filings show about AOA Dx and its b
• Apero HealthApero Health has raised about 800K dollars across five rounds per aggregator data, with no SEC Form D on file under its name. Here is what the record
• Apprentice HealthFour data providers report four different totals for this YC Summer 2018 company, and SEC EDGAR holds no Form D under either of its names.
• ArchFormA single 2020 Form D for $7,842,080 sold to 15 investors, no fund named on the filing, and no Regulation D notice in the six years since.
• Arctic HealthPitchBook reports Arctic Health raised $500K from Menlo and Fortitude Ventures, but no SEC Form D exists under the company's name as of September 2026
• Argon AIArgon AI sold $5,515,000 to 31 investors in June 2024 and announced it thirteen months later. Reading the filing, the checks and the board.
• AriniA $500K seed round two independent trackers confirm, no Form D found on EDGAR, and conflicting reports of extra funding from an aggregator.
• ArintraSeries A of $21M and Series B of $25M, a company-reported $51M lifetime, and the only SEC paper filed by an angel syndicate. What the filings show.
• Arpeggio BioSEC Form D filings show Arpeggio Bio sold over 46 million dollars from 2019 to 2025, including a large November 2025 round before its 2026 wind down.
• Asha HealthA reported 500 thousand dollar seed round, no SEC Form D on file, and trackers that disagree on funding, investors and even the company location.
• Asher BioThree rounds from Third Rock, Wellington and RA Capital, with AstraZeneca and Bristol Myers Squibb on the cap table. What the Form D filings show.
• Astek DiagnosticsSix Form D offerings, $4.15M of equity sold, $1.54M of NSF grants and a $15M round still open. The filings behind Astek Diagnostics, read closely.
• AthelasAthelas Inc. filed a single Form D for $54.4M sold in 2022. Since the Commure merger, the only Athelas filings on EDGAR belong to third-party SPVs.
• Atlas DiscoveryAtlas Discovery has no Form D, no federal grant and no priced round on record. What the YC standard deal and the reported revenue actually show.
• AttunementNo Form D on file for Attunement. Aggregators disagree on a reported $500,000 YC round, and a founder claims 1.5 million.
• AudioFocusA Y Combinator Summer 2019 hearing aid company with no Form D, no federal grant and no announced round. What the patent and the gaps actually show.
• AuricleAuricle Health has no SEC filing of its own. The Form D vendors attach to it belongs to another company. What the record actually shows.
• Avelis HealthAvelis Health has closed a $500,000 YC pre-seed and an undisclosed seed round with no Form D on file. Here is what the funding record actually shows.
• AvoraAvora reports a $2.3M seed led by CRV, but no matching SEC Form D exists yet. See the funding timeline, gaps, and what the public record actually conf
• Avro Life ScienceAbout $2.2 million reported in a single 2018 seed round, roughly $135,000 non-dilutive, and an empty SEC file because the issuer is Canadian.
• Axle HealthAxle Health reports $10M in Series A funding and a $4.2M seed round, but no Form D for the company appears in SEC EDGAR.
• b12 LabsA $500,000 seed round is reported for this Y Combinator chemistry AI startup, but no SEC Form D confirms it. See what the filings do and do not show.
• BByBBy reported a $3 million seed round in May 2023. No SEC Form D for the company has been found. Here is what the record shows.
• Beacon HealthSEC filings show a $44,000 SAFE vehicle from 15 investors, far short of the $500,000 total the company claims, with no Form D filed in its own name.
• BemloA $3.3 million seed round, an undisclosed acquisition and five years of loss making revenue at Bemalong AB, per Bemlo's public filings.
• BeWell DigitalBeWell Digital raised a $125K accelerator round and never filed a Form D. See what the SEC and MCA records show for this now Inactive teleradiology st
• BikantaBikanta raised a single seed round, filed no Form D, took no federal grants, and wound down. The capital record and the gaps in it, read in detail.
• BillionToOneBillionToOne raised about $400 million privately with no Form D of its own, then $314.0 million in its November 2025 Nasdaq IPO. What the filings show
• BiocartesianNo SEC Form D found for Biocartesian. Aggregators disagree on whether it raised $500,000 or nothing at all. Here is what each source says.
• BiocognivOne Form D, a $6M seed, $509,630 in federal grants and a $15.0 million sale to BETA Technologies. The arithmetic behind Biocogniv's capital record.
• BiodockBiodock announced $2.1M in 2021 and reports $3.8M raised. No SEC Form D exists. What the public record shows about the capital behind the platform.
• BIOS HealthA reported $20M round the company never sized, $1.49M in US federal awards, and UK accounts showing 13.69M pounds owed to the Delaware parent.
• BioStack PlatformsA look at BioStack Platforms funding record: a $250,000 SAFE held by Robinhood Ventures Fund II and no Form D filed under the company's own name.
• Blank BioBlank Bio's $7.2 million seed round, the SPV that filed with the SEC months earlier, and what the filings show about its funding, as of September 2026
• BloomAPITwo 2017 Form D filings totaling $3.25M offered and $395K sold, a reported $2.4M seed, and nothing on the SEC record since March 2017.
• Blueberry PediatricsA Y Combinator pediatric telehealth company with seven reported rounds, zero SEC Form D notices, and tracker totals that differ by 6 million dollars.
• BluumBioSeven financing events, seventeen listed investors, five patent families and zero SEC filings. The only auditable number is a $188,466 NIH award.
• BodyportBodyport reported $15.8 million raised through a 2020 Series A led by Boehringer Ingelheim. SEC EDGAR holds no Form D for the company at all.
• Bot MDBot MD raised a US$5M Series A led by Monk's Hill Ventures in 2021. No Form D exists. Reading the seed conflicts, the 2025 investor and the gaps.
• BrainKeySeven years of operation, zero Regulation D filings, and four data providers reporting totals from 150,000 to 350,000 dollars for the same company.
• Brave CareSix Form D filings, a Mednax-led $25M Series B and a secured venture loan marked to $24,574. The capital record behind a pediatric clinic chain that c
• Breathe Well-beingWhat press announcements and India's MCA records show about Breathe Well-being's roughly $12.6 million in funding, with no SEC Form D on file.
• Bristle HealthA $3M seed announced in 2022, no Form D anywhere in SEC EDGAR, no federal grants, and four years of revenue funded building since then.
• Brown FoodsBrown Foods has disclosed one $2.36M seed round from June 2022 and has filed no Form D with the SEC. Here is what the public record does and does not
• Bunkerhill HealthBunkerhill Health has raised $55 million across seed, Series A and a $25M Series B led by Khosla Ventures, with no Regulation D notice on file at the
• C16 BiosciencesThree SEC Form D offerings record $28.9 million of equity sold, $5.26 million left unsold in 2023, and no new filing since that March.
• Caelum HealthOne reported seed of $120,000, zero SEC filings, and no capital disclosed after August 2017. What the absent Caelum Health paper trail actually shows.
• Cair HealthCair Health's funding profile: a $500K accelerator check, an undisclosed seed round, a mismatched investor list, and no Form D on SEC EDGAR.
• Caire HealthNo Form D on file and one disputed $125,000 seed figure. What the public record does and does not show about Caire Health's capital.
• Cairns HealthNo SEC Form D exists for Cairns Health. Two paid databases disagree on total funding by nearly sevenfold, and one has its own acquisition backward.
• Call9Call9 raised $34 million and never filed a Form D. Its venture lender's SEC filings track the 2019 collapse quarter by quarter, to the dollar.
• CamberWhat Camber has disclosed about its $50 million in funding, where investor accounts conflict, and why no SEC Form D has surfaced under any name tried.
• Cambridge Cancer GenomicsAbout $4.5 million raised, no Form D on record, and UK accounts that track the cash from 981,051 pounds down to a strike off application in 2022.
• Candid HealthCandid Health reports about $219.5 million raised. The only Form D on file shows $104.9 million sold to 12 investors, short of the announced round.
• Care GPCare GP names two backers and a YC batch but no dollar figures and no SEC Form D. A dry read of what is disclosed about its capital and what is not.
• CareforceY Combinator, CRV and a health foundation back Careforce. The one Form D under that name belongs to a different company. Here is the arithmetic.
• CareLedgerCareLedger raised a $120,000 seed alongside its 2015 Y Combinator batch. No SEC Form D exists, and no later financing was ever reported.
• CareMessageNo Form D, no cap table. Twelve years of IRS Form 990 filings show a near failure in 2019, an earned revenue recovery, and a 147 percent grant surge i
• CareRevTwo announced $50M rounds, $70M in committed debt, a reported $600M valuation, no Form D of its own, and an acquisition closed on undisclosed terms.
• CareSwiftOne reported round of $500,000 tied to Y Combinator, no SEC Form D on file, and two sources that disagree on the date of that funding.
• Carrot FertilityThree priced rounds totaling $115 million, none of them on file with the SEC. What the empty securities record and two federal dockets show.
• Catena BiosciencesOne $2.35M seed extension, one $299,379 NIH grant and zero SEC Form D notices. What the public record does and does not show about Catena Biosciences.
• CB TherapeuticsA withdrawn crowdfunding round, $2.01M of reported revenue, a $45M asking valuation and zero Regulation D filings in ten years of operation.
• CellbyteCellbyte's seed round shows two different figures across outlets and no SEC Form D on file. Here is what the public record actually shows.
• CellChorusCellChorus holds $8.87 million in NIH and NSF awards, $175,000 in disclosed equity and no Form D on record. What the federal filings actually show.
• CellTypeThree Sydecar SPVs raised $1.54 million for CellType in early 2026. No Form D has been filed under the company's own name. Here is what the filings sh
• Centaur LabsCentaur Diagnostics has one SEC Form D on file from 2021. Its 2024 Series B, a federal grant, and named customers are checked against that record here
• Certainly HealthCertainly Health announced $2.3 million in December 2023 and has no Form D on file with the SEC. The arithmetic, the runway and who carried the risk.
• Circle MedicalCircle Medical raised about $12M in primary capital, sold control to WELL Health for $14.3M, and now sits in a sale process. What the filings show.
• Cisterna BiologicsTwo thirds of Cisterna Biologics capital on record is non-dilutive: $500K reported pre-seed in 2022, three federal Phase I awards, and no Form D.
• Claim HealthClaim Health announced a $4.4M seed round in January 2026, but no SEC Form D has surfaced yet. Here is what the filings and the press each show.
• ClaimGlideClaimGlide has one reported accelerator investment and no SEC Form D on record. A look at what the public filings, and their absence, actually show.
• ClaraClara says it raised $12 million pre-seed in 2026. No SEC Form D has surfaced under its name. Here is what the public record shows so far.
• ClarionClarion has raised money in four tranches since 2024, reportedly totaling 15.8 million dollars, with no SEC Form D found under its name.
• Clear GeneWhat the record shows on Clear Gene: a $293,237 NCI SBIR award, a 2018 accelerator cheque, undisclosed later rounds and no Form D anywhere.
• Clear GeneticsAbout $2.5 million of venture capital, no Form D ever filed, and a $50,062,000 purchase price recorded by Invitae in November 2019. What the filings s
• ClinikallyTwo independently reported rounds worth $3.1 million, no SEC filings, and a funding database claim of $6.6 million this research could not corroborate
• Clip HealthClip Health raised about $53 million, but $43.9 million of it was federal grants and contracts, and no Form D was ever filed with the SEC.
• Cofactor GenomicsThree Form D filings, $18.8M sold, and a December 2025 Labcorp and Ascension investment with no SEC notice. Reading the Cofactor Genomics record.
• CollectlyCollectly raised $29 million led by Sapphire Ventures and filed no Form D. The only SEC trace of its cap table sits in SAP SE annual reports.
• CombineHealthCombineHealth reports about $1 million raised through April 2023, but no SEC Form D exists under its name. Here is what the record actually shows.
• Comet HealthComet Health raised about $125,000 and never filed a Form D. What SEC, CMS and vendor records show about a YC pelvic floor therapy company.
• Comprehend SystemsEight SEC Form D filings record $64,184,015 sold between 2013 and 2019, against a last announced total of $44.5 million and an undisclosed exit.
• ConvexiaData aggregators say Convexia raised about $500,000. No SEC Form D confirms it, and the aggregators do not agree with each other on team size or reven
• Copper HealthCopper Health has no SEC Form D on file and no reported venture round beyond a standard Y Combinator investment, per PitchBook, Tracxn and GetLatka.
• Coral GenomicsAbout $2M of seed equity and $2.95M of NIH SBIR money, no Form D on file, and an asset sale recorded only in a clinical trial registry.
• CoreCareCoreCare disclosed a $3 million seed round in 2020. Later financings are undated and no Form D has ever been filed for the company in SEC EDGAR.
• Correlia BiosystemsTwo Form D filings for the Berkeley proteomics tools company, including a 2020 round filed five weeks early and $2.57 million above the announcement.
• Corveus MedicalCorveus Medical's only SEC filing is a 2021 Form D under its former name Caridian Medical, reporting $75,000 sold to two investors against $350,000 of
• CraniometrixCraniometrix says it raised over $21 million and reached $8M ARR. The SEC has no filing under that name. What the CMS records do show.
• CrohnologyPitchBook lists $20K raised. The founder recalls about $350K. No SEC Form D exists. Here is what the funding record actually shows.
• CrowdMedCrowdMed raised $2.4M in reported seed capital, then $403,471 from 608 Regulation Crowdfunding investors. The Form C record, read line by line.
• Culture BiosciencesOne 2020 Form D covers $21.6M of a reported $100M. The $80M Series B and the December 2025 Series C were never filed. What the records show.
• CurebaseTwo Form D filings cover the whole pre-Series B total. The $40M Series B has no filing behind it, and nothing has been filed with the SEC since July 2
• Current FoodsCurrent Foods raised millions in named venture rounds but never filed a Form D under Kuleana or Current Foods, and its 2023 sale price stayed undisclo
• CurvenoteCurvenote's CAD 1.4 million seed round, checked against SEC EDGAR filings and a third party revenue estimate that does not match the company's own num
• Cytera CellWorks, now MytosOne Form D for $18.0M from 93 investors, a $19M announced Series A, and UK accounts showing a 3.9 million pound loss and halved cash.
• DarmiyanDarmiyan's SEC record shows $9.97 million sold across two Form D offerings, a fully sold 2023 round, and nothing filed since October 2023.
• Dashlabs.aiDashlabs.ai has raised a reported 1.39 million dollars from Philippine and Asian investors, with no SEC Form D found for the company.
• Data Driven BioscienceEight years, six named investors, no Form D on file. Federal small business awards account for about 94 percent of every traceable dollar.
• DatricsDatrics has disclosed one 2021 seed round and no SEC filing of any kind. Here is what the public record shows and does not show.
• Daybreak HealthDaybreak Health reports $25 million raised through a 2023 Series B, yet files no Form D. Two 2025 Sydecar syndicates and district contract prices tell
• Dear BrightlyDear Brightly has raised $125,000 on record since Y Combinator W18 and has never filed a Form D. What the absent filings and the data providers show.
• Decoda HealthDecoda Health says it raised $4.5 million led by Y Combinator. No Form D backs the figure, and trackers report far smaller numbers. Here is the gap.
• Deep MeditateThe only funding event on record for meditation app Deep Meditate is a Y Combinator investment with no matching SEC filing.
• DeleeOne Form D and three crowdfunding rounds totalling $2.75 million, against revenue of zero in every fiscal year Delee reported to the SEC through 2022.
• Delfino AIPitchBook credits Delfino AI with $500K raised. GetLatka reports no funding data. No SEC Form D exists for either figure to check.
• Diffuse BioNo Form D exists for Diffuse Bio. Four databases report $500K raised, one says $130K, one says zero. What the patent and price list show.
• Digi-PrexDigi-Prex capital record: a $5.5M 2019 seed, an $82,500 Globevestor SPV Form D, and an active Indian company with no registered charges.
• DigistainA Delaware parent, a small UK subsidiary, about $1M of reported equity and 359,812 pounds of Innovate UK grants. What three registries show.
• DirectShiftsSerent Capital backed DirectShifts in 2022, size undisclosed. No SEC Form D was found, and a $45 million claim has no filing to match it.
• Ditto BiosciencesFour named investors, about $500,000 on the record and no SEC filing at all. What the databases show about this YC W26 parasite protein company.
• dNovodNovo announced a $2.7M seed round in 2022. No SEC Form D was ever filed under the company's name. Here is what the record shows and does not show.
• DocbotDocbot raised a 2.045 million dollar seed and a 4 million dollar Khosla-led Series A, filed no Form D, and sold its assets to Satisfai Health.
• Docura HealthDocura Health has one investment on record, a $500K Y Combinator check. No Form D, no named lead investor, and an unresolved address conflict.
• DocVitaA $125K Y Combinator check, an undisclosed 2021 seed round, and MCA filings that do not agree with bootstrapped or zero funding claims.
• DodoDodo has a reported 500K dollar Y Combinator seed and no SEC Form D on file. See the filings, the gaps, and a funding claim likely tied to a different
• Dorian TherapeuticsDorian took more from the NIA and NCI than it disclosed from investors, filed no Form D of its own, and exited to Altos Labs on undisclosed terms.
• DoseDrDoseDr raised $120,000 on record, filed no Form D, won no federal grant, and was logged out of business in December 2019. What the absences mean.
• Dr. TreatSEC records show one investment vehicle tied to Dr. Treat, while the veterinary clinic company itself reports a $10.5 million to $11 million seed roun
• DrChronoDrChrono raised one filed equity round in 2011, then financed on debt, and sold to EverCommerce for $181.9 million in cash in November 2021.
• Dropprint GenomicsDropprint Genomics has no SEC Form D on file. Its only dated financial event is an undisclosed acquisition by Immunai in March 2021.
• EdenThree SEC Form D filings under Eden's legal name, Higia Inc, show what investors actually put in, compared with the rounds the company announced in th
• Egress HealthNo SEC Form D, conflicting founding dates, and a Y Combinator acquired status with no acquirer found. What the public record shows on Egress Health.
• Elemeno HealthNine Form D offerings, three crowdfunding portals, a valuation cut from $20.0M to $6.0M, and no new securities notice since February 2024.
• EligibleTwo Form D notices, $2,682,896 sold, nothing filed since January 2015, against a company-reported total above $25 million. What the record shows.
• ElytheaElythea has no SEC filing on record. What PitchBook, Tracxn, the prize releases and an abandoned patent say about the capital behind the company.
• EmberEmber raised a $4.3M seed led by Nexus Venture Partners in Nov 2025. No matching SEC Form D has surfaced under any name tied to the company.
• Empirical HealthEmpirical Health reports a $500,000 pre-seed and no SEC Form D. The filings, the growth multiples and the licensure record, read closely.
• EncepHeal TherapeuticsFour NIH awards worth $793,836, a $3.3 million headline that never landed, and zero Regulation D filings. What the award records show.
• Endpoint HealthTwo announced rounds totaling $64 million, a Grifols commitment of up to $25 million, one $679,115 BARDA contract, and zero SEC filings by the issuer.
• EnfluxSEC EDGAR shows no Form D for Enflux, Inc. The public record points to a Y Combinator check and a Kickstarter raise, with a higher total unverified.
• Engage BioEngage Bio filed no Form D, took one $865,162 NIH SBIR award, and sold to Eli Lilly for up to $202 million in cash. What the public record shows.
• Entelexo BiotherapeuticsWhat the SEC record shows: one Regulation CF offering, 80 investors, no Form D, and no filing since July 2021 for this Irvine exosome startup.
• EntvinEntvin has one disclosed round, $500,000 from Y Combinator, and no SEC Form D on file. What the India registry and the press coverage actually show.
• EnzymeOne announced seed round, zero SEC Form D filings, four conflicting funding totals, and an undisclosed 2025 sale to Greenlight Guru.
• Eos AITracxn and PitchBook both report a $500,000 Eos AI investment tied to Y Combinator, but disagree on its type, and no Form D is on file.
• EpinomaEpinoma has raised roughly $5 million since Y Combinator S21, has filed no Form D and holds no federal grants. Reading the capital record of a tools s
• Equator TherapeuticsFour NIDDK SBIR awards total $3.91 million against $625,000 in disclosed equity. The SEC has no Form D on file for this preclinical obesity company.
• Equipt HealthThe whole capital record for Equipt Health: a $125,000 accelerator deal in 2021, no Form D on file, two named investors, and a 2025 out of business ma
• Eris BiotechEris Biotech has one disclosed figure, three named investors and nothing on file with the SEC. Reading a preclinical cap table built from accelerator
• Eugit TherapeuticsEugit Therapeutics has one confirmed federal grant on record. No SEC Form D filing exists, and its Y Combinator investment stays undisclosed.
• Evolvere BioSciencesA UK biotech with about $500K reported raised since 2021. No Form D exists to check it against, and Companies House shows only nominal share values.
• Evry HealthEvry Healthcare disclosed $7.32M from 32 investors on a single 2021 Form D, then sold to Globe Life for what the buyer called an immaterial amount.
• ExamediForm D detail on Examedi: $22,499,000 sold to 41 investors in 2022, two Sydecar vehicles in 2026, and a down round with no filing.
• ExcepgenExcepgen says it raised $14 million in seed funding from named investors, but no Form D appears under its name at the SEC. Here is the funding record.
• Exin TherapeuticsA Form D showing $2,162,300 sold to 28 investors, filed 449 days after the first sale, against trackers that report only $500K.
• ExonicWhat two data aggregators report about Exonic's seed funding, the investors they name, and why no Form D backs up the numbers.
• ExperimentExperiment has never filed a Form D of its own. A 2015 Wefunder vehicle sold $75,000 to 27 investors, and a 501(c)(3) now files the clearest numbers.
• Farmako HealthcareAbout 1.6 million dollars in press reported funding, no SEC Form D on record, and a gap between two aggregators on Farmako's total funding raised.
• FastFarmaFastFarma raised a reported 125,000 dollars from Y Combinator plus an undisclosed round, then closed in December 2022. No Form D was ever filed.
• Felix BiotechnologyFederal grants, a $1 million Cystic Fibrosis Foundation award, no Form D on file, and a licensing deal that hinged on a Series A that never closed.
• FidoCureOne Health Company raised about $16M by 2020 and has never filed a Form D. Two small 2025 syndicates did. The arithmetic behind the filings.
• Finni HealthOne announced seed round, no Regulation D filing and an asserted Series A with no number attached. The public capital record for Finni Health.
• FitiaFitia joined Y Combinator in 2021 and reportedly raised a seed round. No SEC Form D has ever been filed under its name. Here is what the record shows.
• FlintFlint has raised about $4.12 million per PitchBook, with no SEC Form D found under its name. Rounds, investors and gaps in the record, explained.
• Float HealthFloat Health sold $9.99M to 10 investors in June 2023 and announced it nine months later. Nothing has been filed with the SEC since August 2023.
• FlowlyNo SEC Form D on file for Flowly or its legal name, Tamade. A $1.2M NIH grant is confirmed; aggregators disagree on the rest of its funding total.
• Forcyte BiotechnologiesA Form D corrected from $1M to $160,000 in five days, $3.19M of NIH grants, and a $5.7M company total the filings never reach.
• Forever LabsOne announced $2M round in 2018, no SEC filing under the company name, and a client count that has not been updated in public since November 2020.
• Fortuna HealthFortuna Health raised a reported $22 million across two rounds. What the single SEC Form D shows about investors, timing and the board.
• Framewise HealthA $500,000 Y Combinator accelerator investment is the only funding event PitchBook has on record for Framewise Health. No SEC Form D found.
• FrekilFrekil has no SEC Form D on record. Trackers disagree on whether its seed round totals $500,000 or $1,000,000, and who besides Y Combinator invested.
• FurmacyFurmacy raised a $125,000 YC seed round, was bought by Wag! Group Co. for stock in 2022, and sold to MWI Animal Health for undisclosed cash in 2025.
• FusePitchBook and Delight Ventures name four backers of Fuse, but no dollar figure is public and no SEC Form D exists for the company or its parent.
• Future FieldsFuture Fields has announced about $21.9M across four raises, including a $5M Canadian federal grant. Why the published totals disagree, and what no fi
• FutureClinicFutureClinic says it raised $5 million. No SEC Form D exists, and PitchBook puts total funding at $500K. Here is what the record shows.
• Galen AIGalen AI raised a $500K YC investment and an undisclosed round before Oura Health acquired it in April 2026. No Form D was filed, and deal terms went
• GamgeeA $4 million seed round reported by press and the company, with no matching SEC filing found. What the public record shows about Gamgee's capital.
• GEn1E LifesciencesGEn1E Lifesciences has filed two Form D notices since 2022, reporting $22.5 million of equity sold and not one outside vehicle. The arithmetic, read c
• General ProximityGeneral Proximity has announced $16M, then $12M more, then over $20M total. Only one Form D exists, filed by a small investment vehicle, not the compa
• GenomelinkFour databases report four different totals for Genomelink and no SEC Form D exists. The rounds, the named investors, and the arithmetic behind them.
• Gerostate AlphaSeed of $2.1M, two 2021 Wefunder offerings, a restated balance sheet, and no SEC filing since April 2022. What the Form C record actually shows.
• Gilgamesh PharmaceuticalsEleven Form D filings across two entities, a $60 million Series A sold in full, three Sydecar and Prime Movers Lab vehicles, and announced versus file
• Ginkgo BioworksForm D records, SPAC proceeds, PIPE, stock compensation and cash burn for Ginkgo Bioworks, read straight from SEC filings as of September 2026.
• Glass HealthTwo announced rounds totaling $6.5 million, nothing since September 2023, and zero Form D filings in EDGAR. What the record does and does not show.
• Gradia HealthA $4.2M seed round is confirmed by press, but no Form D was found and three sources give three different totals for money raised.
• Granza BioGranza Bio closed an oversubscribed $7.14M seed in 2024. Here is what the corporate filings show, and what has not yet appeared on SEC EDGAR.
• Guardian BioWhat is known about Guardian Bio's money: a Y Combinator investment, two small grants, a $3 million seed target that never closed, and no SEC Form D o
• H1Four Form D filings under H1 Insights account for $271 million sold. One is acquisition stock, not cash. The last outside valuation dates to 2021.
• Haplotype LabsFive investors, $220,000 each, fully subscribed in April 2024. Nothing filed since. Reading the SEC record of a one person genomics software company.
• HappiLabsHappiLabs raised one Y Combinator check in 2018, filed no SEC Form D, and was bought by Science Exchange in 2025 for an undisclosed price.
• HarborHarbor has no SEC Form D on file. PitchBook shows $500K raised from YC and Core Innovation Capital against a $1.93M services contract.
• Harmonic DiscoveryHarmonic Discovery announced an $8 million seed in 2022. No SEC Form D, no federal grant, and an accelerator that states a different total.
• Health HarborHealth Harbor reports a $500,000 pre-seed round from Y Combinator, but no SEC Form D exists under its name. Here is what the record shows.
• HealthKeyHealthKey's only SEC record is a $484,833 SPV filed in January 2025. Here is what the filing shows and what the filer name leaves out.
• HealthlaneA $150K YC check and a $2.4M seed round with no SEC Form D on file, set against $400K plus in unpaid debts documented in 2022 and 2023 reporting.
• HealthSherpaTwo priced rounds totaling $9.37M, a $54.27M post-money valuation set in 2018, and no Form D in SEC EDGAR. Reading the capital record.
• Helium HealthTwo announced rounds totalling $40 million, grant records from Gates and GSMA, a $10.9 million loan book, and zero securities filings to check them ag
• Helix NanotechnologiesA named cap table, a $6.4M reported total from 2020, zero Form D filings, and a $15M spinout seed led by OpenAI. What the SEC record holds.
• HelpNowHelpNow has no US entity and no SEC filing. Here is what PitchBook, Tracxn and a founder interview say about its funding, and where they conflict.
• HelpWearHelpWear's capital record is competitions and accelerator cheques: $120K tracked, $100K from six Dragons, and no SEC Form D under any spelling.
• HepaTxHepaTx has $699,755 in NIH grants, one 2021 SPV Form D, and a September 2026 Reg CF offering. What the SEC filings show about its balance sheet.
• HeyDoctor$2.35 million sold in the only Form D, a $14.3 million cash exit to GoodRx in 2019, and a $19.5 million sale of the technology to Wheel in 2022.
• HistoWizTwo Form D notices totaling $1.34 million, then silence. What the SEC record shows about HistoWiz and what the 2021 Series A left out of it.
• Hive HealthOne announced round of 6.5 million dollars, an undisclosed HMO acquisition, and why the only Form D under this name is a different company.
• Humane GenomicsWhat the SEC filings and press reports show about Humane Genomics funding, from a $125K YC check to an undisclosed Series Seed led by Union Square Ven
• Illuminant SurgicalAn $8.4M seed announced in April 2026, about 35 percent of it federal grant money, and no Form D or any other SEC filing on record for the company.
• In Your CornerA YC Summer 2014 online counseling company with no Regulation D filing, undisclosed rounds, merchant loan debt and a domain sale. The capital record,
• Indee LabsEleven years of financing with no Form D on EDGAR. Federal awards of $3,304,505, a $2.6M seed led by Founders Fund, and a patent portfolio put to a br
• Industrial MicrobesAbout $3.55M in federal awards against a company-reported $10M total, a $1.55M Defense planning award, and zero Form D filings on EDGAR.
• InflowInflow filed a single Form D for $13,571,773 from 12 investors, $2.57M above its announced $11M Series A. The filings, the gaps and the 2026 acquisiti
• InitoInito raised $29 million in December 2025 on a total it reports as $45 million. No SEC filings exist, and the totals do not reconcile.
• InnaMedInnaMed raised $2.35M across two crowdfunding rounds on the public record. No Form D backs its later claim of $4.5M from venture investors.
• InnoVeinForm D filings show $10.7 million sold in 2018 and only $2.5 million of an $11.9 million offering in 2023, plus $1.6 million in NSF SBIR awards.
• InpharmDInpharmD raised a $6.05M seed led by 645 Ventures in 2023 and has filed no Form D. Reading the numbers that exist, and the ones that do not agree.
• inSoma BioFour Regulation D offerings, $6.89M in equity sold, $5.32M in federal awards, and a claimed total running about $2M ahead of the public record.
• InstalabA reported $500,000 raise from Y Combinator and Liquid 2 Ventures, and no SEC Form D found to confirm it. What the trackers say about Instalab.
• InstapathInstapath sold $1.79M in a 2019 Rule 506(b) offering to 20 investors and has drawn $1.72M from NSF. Nothing filed with the SEC since.
• Intact TherapeuticsPublic agencies put $2.46M into Intact Therapeutics. No Form D exists, databases disagree on equity, and a $452.5M option deal lapsed in 2026.
• IntellectIntellect reports more than $22 million raised across a seed, a two part Series A and two strategic corporate investments, with no Form D under its ow
• InvertInvert sold $20.1 million to 16 investors in a June 2024 offering. What the Form D shows, what the databases miss, and why the round has three names.
• InVision Medical TechnologyTwo FDA clearances, a CPT code and a Medicare add-on on roughly $500,000 of disclosed capital, with no SEC Form D anywhere on the record.
• InvitrisInvitris has drawn EU and Bavarian grants worth millions but only one small SEC filing. Here is what the public record shows about its capital structu
• IsablAbout $5.0 million in disclosed capital for Isabl, two fifths of it federal grant money, with zero Form D filings on record at the SEC.
• iSono HealthiSono Health funding profile: $14.7M reported, $3.71M in federal grants, a Sydecar SPV and a $3M seed round, read against SEC Form D filings.
• Jeevam HealthA look at Jeevam Health's $947,000 in disclosed India-only funding, its investors, and the corporate registry record after the product went offline.
• Joon HealthJoon Health has two press-reported rounds totaling about $8.5 million since 2022, and no SEC Form D on file to confirm either one. Here is what the re
• JunctionJunction raised $2.9M seed and an $18M Series A led by Creandum. No SEC filing exists, so the capital record sits in British company filings.
• Junction BioscienceNo SEC Form D exists for Junction Bioscience. A third party tracker lists a $500,000 round that does not match the company's own account.
• JunoJuno has one reported investment, Y Combinator's standard check, and no Form D on file under its own name or its founders earlier company, SharedGenes
• KabilahA $500,000 seed round, two investors named by aggregators, and no SEC Form D found under Kabilah's name. What the public record shows and what it does
• Kaigo HealthKaigo Health took a standard $500,000 Y Combinator check in 2025. No SEC Form D has been filed, and total funding claims from aggregators conflict.
• KenotaSEC filings, FDA records and press reports on Kenota funding, from its 2016 seed to a reported $11 million Series A and an inactive status in 2026.
• Kern SystemsThe capital record for the DNA data storage startup: one accelerator entry, a $150,000 total, no Regulation D notice and no federal award.
• Kernal BiologicsThree Form D notices, about $35.5 million of disclosed equity and a federal award of up to $48 million. What Kernal Biologics filings actually record.
• KeylikaKeylika has disclosed $500,000 from Y Combinator in 2022. No SEC Form D or later round has been found on the public record since.
• KilobaserNo SEC filing exists for Kilobaser. Austrian public records show EUR 1.6M invested by 2018, a 2023 insolvency, and a distributor financed buyout.
• KingdomThe only Form D reports $28.4 million sold to 93 investors, filed under Imvela Corp. The company now says $40 million. The gap is about $8.1 million.
• Kip HealthNo Form D, no disclosed round sizes, five named investors, and an acquisition by Modern Health with terms never made public.
• Kivo HealthKivo Health says it raised a $10 million Series A. No SEC Form D confirms it. Here is what the funding record actually shows, and what does not add up
• Kiwi BiosciencesNo SEC Form D, no federal grants, and three databases that disagree on the raise by 16 times. What the public filings on Kiwi Biosciences actually sho
• KlarismoSEC filings show Klarismo raised $2,119,952 across two 2015 Form D notices before the UK company was dissolved in 2019. Here is what the record shows.
• Known MedicineOne announced $7.2 million seed round, no SEC Form D, no federal grants, and an undisclosed 2023 acquisition by Pathos AI. What the public record hold
• KnowtexKnowtex has no SEC Form D on file. Its confirmed $14.99 million VA contract dwarfs the $3.5 million in equity Forbes reported the company had raised.
• KokoKoko raised venture money with no Form D, was acquired by Airbnb in 2018, and now files as a 501(c)(3) with $4.93M of contributions since FY2021.
• Kopra BioA $9.1M seed round, a $100K non-profit award, and no SEC Form D on file yet. Here is what the public record shows about Kopra Bio's capital.
• Lamar HealthNo Form D on file and three data aggregators reporting different totals. What the public record shows about Lamar Health's funding and investors.
• LaminLamin has filed nothing with the SEC. What the aggregators, the German register and the Y Combinator terms sheet reveal about its capital.
• Latent HealthLatent Health raised an $80M Series A in March 2026, agreed on by every outlet that covered it, but no SEC Form D has surfaced under the company's nam
• Lavo Life SciencesNo SEC Form D on record for Lavo Life Sciences, one undisclosed pre seed database entry, and 1.49 million dollars in NSF grants that are the only conf
• LEAH LabsSEC Form D and Form C filings, SBIR and STTR grants, and Wefunder totals for LEAH Labs, a USDA regulated veterinary CAR-T therapy company.
• LegacyThree announced rounds, a total stated four ways, and no Form D on file. What the SEC, FDA and CMS records show about Legacy's capital picture.
• Legion HealthSix Form D filings from 2022 to 2026 show $22.1 million sold, a first priced round in June 2026, and a new outside director on the cap table.
• LemonBoxFour reported funding rounds, no SEC filings, and an aggregator total that does not match the press. What the record on LemonBox actually shows.
• Ligo BiosciencesA pre-seed enzyme design startup with named investors, no Form D on file, and a gap between founder claims and third-party funding data.
• LiliaWhat press reports and PitchBook say Lilia raised, why the totals do not agree, and why no SEC Form D exists for this now inactive startup.
• ListRunnerPitchBook shows $747,000 raised before Commure's 2017 acquisition, but no SEC Form D has been found for the company under either name it used.
• Liv LabsEvery dollar traceable to Liv Labs is grant money or crowdfunding. No Form D exists in SEC EDGAR, and federal awards cover four fifths of the stated t
• LivelyLively raised $117.07 million across three SEC Form D filings from 2018 to 2021, then went quiet. The arithmetic behind the rounds and the asset claim
• LiyfeA reported 150,000 dollar Y Combinator check is the only investment on record. No Form D found. PitchBook marked the company out of business in 2023.
• Loop GenomicsLoop Genomics raised under the name MetaBiotech Corp. The Form D reports $9.18M sold to 12 investors, more than the $8M Series A it announced.
• Loop HealthFour Form D filings by Invoq Health record $100.3 million sold since 2020, including an unannounced $58.8 million offering filed in July 2026.
• LSK TechnologiesVelocity, Y Combinator and angels put roughly $350,000 into LSK Technologies. No Form D was ever filed, and Nicoya bought the company in May 2022.
• Lucira HealthWhat the filings show: $32.5M sold on two Form D notices, a $175.9M IPO, an $80M facility repaid in full, and a $36.4M bankruptcy sale to Pfizer.
• LucisLucis reports about $28 million raised across two 2025 to 2026 rounds, with no SEC Form D on file. See the rounds, the registry record and the open qu
• LullyLully reported about $2.2 million raised from 2014 to 2016. No SEC Form D has been found, and the company appears to have stopped selling its device b
• LumeLume filed no SEC Form D. See why PitchBook and CB Insights disagree on its funding, and what the 2022 Vivian Health deal did and did not disclose.
• Luminate MedicalThree Form D filings show $33.2M sold against a company-stated $50M total. Announcements trail the filings by months, and cheque sizes tripled.
• LumiusAggregators put Lumius funding near $500,000, but no SEC Form D for the company was found. Here is what is and is not on the public record.
• LunaBillLunaBill has no SEC Form D on file. A look at its reported seed round, its unverified investor list, and where the aggregator data disagrees with itse
• LunaJoy HealthLunaJoy Health has announced $6.6 million across a 2023 seed and a 2024 round from the same backers, but no SEC Form D has surfaced under its name.
• LygosAbout $41.7 million of equity sold through 2019, $4.05 million of federal SBIR awards, one unannounced round, and no Regulation D notice since 2019.
• MableSEC filings and UK company records for Mable, the migraine genomics startup, including its 2021 Form D and 2023 dissolution.
• MacromoltekSixteen years, zero securities filings. The NSF awards, the Y Combinator check and the 2017 revenue that explain how Macromoltek stayed unfunded.
• MaiaMaia has a $500K Y Combinator deal and an undisclosed North South Ventures check in 2024, and no SEC Form D found on record.
• Makani ScienceNo Form D, a crowdfunding round that closed at 3 percent of its ceiling, and an annual report that does not show the $10 million the company announced
• Malama HealthThe Form D behind the March 2026 seed round reports $5,315,000 sold to 15 investors. The rest of the $9.2 million headline is grant money.
• Mango MedicalNo SEC Form D found for Mango Medical. Reported funding ranges from $500,000 to $8.3 million depending on the source.
• Mark Cuban Cost Plus Drug CompanyOne backer, a $1.3 million seed, an $11 million Dallas plant and zero Form D filings. What the public record shows about how this company is funded.
• MatchaMatcha has one accelerator deal on record and no SEC Form D under any name. See what PitchBook, LinkedIn and the company itself each claim.
• MatrubialsMatrubials has little verifiable equity. A $286,968 NIH grant is its largest documented check, and no Form D has ever been filed with the SEC.
• MDalgorithmsAbout $6M raised on aggregator data, no Form D in SEC EDGAR, 1,178 percent reported revenue growth, and an ad budget larger than the venture total.
• mdhubmdhub is a Y Combinator company with about $500,000 in tracked funding. Here is what four data trackers show, and why SEC EDGAR has no Form D on file.
• MeasuredFive years of operation with no Regulation D filing and no disclosed round. What the public record does and does not show about Measured.
• Mecha HealthA $4.1 million seed led by Valia Ventures, zero SEC filings, zero federal grants and no FDA submission. What the record does and does not show.
• MedcryptSEC filings record $39.69M sold across four Medcrypt offerings, including $8.3M of debt in February 2025 that the company never announced.
• MedervaTwo trackers report a $500K 2022 round. The one SEC filing on record is a 2026 Sydecar SPV, filed under a name that is not the operating company.
• Medicare VoxMedicare Vox reported a 15 million dollar Series A in 2022 and was acquired in 2026. No SEC Form D was found for the company under any name tested.
• Medinas HealthA single SEC Form D, a larger round with no filing, and third party totals that do not agree. What the record shows about Medinas Health's money.
• MedisasMedisas raised $10,589,641 from 39 investors in a December 2016 Form D. It is the only SEC filing the company ever made. Reading what it shows.
• MediSearchMediSearch, a Y Combinator medical search company, has $500,000 reported raised and five named investors, with no SEC Form D or UK filing to confirm i
• Medium BiosciencesFunding profile of Medium Biosciences: a $125K Y Combinator check, undisclosed later rounds, six listed investors, and no SEC Form D found in public r
• MedMe HealthMedMe Health raised about C$4.7M in equity through 2022, led by M12, plus an undisclosed CIBC credit facility in 2025. No Form D found. Rounds and gap
• MedmonkMedmonk, YC W12 and Rock Health alum, shows about $170K in reported seed money and no SEC Form D. See what the databases agree on and where they confl
• MednetOne reported 2017 seed of $1.3M, $2.23M in NSF and NCI awards, and zero Form D filings. What the public record shows about who funds Mednet.
• MedplumMedplum has no SEC filings at all. Three databases report its total raised as 6.5 million, 550 thousand and 125 thousand dollars. Reading the gap.
• MedumoOne Form D shows $1,966,044 sold to 36 investors in January 2018. Royal Philips acquired Medumo eighteen months later on terms never disclosed.
• MedXTMedXT, a Y Combinator W13 cloud radiology company, was acquired by Box in 2014. The reported Form D shows $3.84 million in Box stock. Earlier funding
• Memora HealthThree announced rounds totaling $80.5 million, no Form D on file with the SEC, and an all stock sale to Commure reported at $30 million in stock.
• MentalHappyA $1.1M seed, three Regulation Crowdfunding offerings and a 2024 Form D that was 75 percent unsold. What the MentalHappy filings show, line by line.
• Menten AIMenten AI reported a $4M seed in 2020 and later cited $6M. No SEC Form D was found. Rounds, investors, and what the public record does and does not sh
• Meru HealthMeru Health filed four Form D notices from 2019 to 2021 covering $42.4 million sold, and nothing since. The arithmetic behind the announced rounds.
• MetriportMetriport raised $2.4M in 2022 and $26M in August 2026 led by Matrix. The SEC holds no Form D for it. What the disclosed numbers add up to.
• Million MarkerNine NIH small business awards total $4,780,117 and no Form D has ever been filed. The capital picture for Million Marker, read from public records.
• Mindstate Design LabsOne Form D reports $12.7M sold of $15.1M offered from 43 investors in November 2024, well above the $11.5M seed the press still quotes.
• Modern FertilityModern Fertility raised $22 million across a Y Combinator round, a $6M seed and a $15M Series A, then sold to Ro for a reported $225 million. No Form
• Modern HealthModern Health reports more than $170 million raised. Only $14.05 million appears across the three Form D filings on record, and none since January 202
• MoichorTwo SEC Form D filings record $11,268,086 sold at Moichor. The company announced $4 million, and the larger offering was never announced.
• Momo MedicalMomo Medical raised $8.89M of a $10.59M Form D offering in 2024 and refinanced its Dutch retail bonds in 2026. The filings read closely.
• Morphle LabsMorphle Labs raised a $5 million Series A led by Inflexor Ventures. No SEC Form D exists, so the audited numbers here are Indian filings.
• Nabla BioNabla Bio raised $37 million across a seed and a Series A, filed no Form D, and announced over $1.5 billion of contingent pharma milestones.
• NearWaveNearWave has filed no Form D, and public totals for the company range from 520,000 dollars to 2.4 million. The arithmetic behind that gap, explained.
• NectomeNectome has $915,835 in NIMH awards on record and no Form D in eight years. What the public record shows about its capital, and what it does not.
• NephrogenA $309,000 syndicate filing, a $325,000 NIH grant and a reported $2 million pre-seed. What the Nephrogen filings show, and what they leave out.
• Nest GenomicsAn $8.5M seed announced in 2023, no Form D on EDGAR, and NHGRI awards covering a fifth of the capital. Reading the Nest Genomics record.
• NimbleRxEleven years of venture money left a single SEC Form D. The arithmetic on $14,749,877 from nine investors, and what the filing does not say.
• Noora HealthA nonprofit with no Form D. Eleven years of IRS Form 990 filings show a $52M year in 2021 and a reserve now being spent down.
• Notable LabsSix Form D offerings, about $82.2 million sold, a $10.3 million pre-merger placement, and the cash burn that set the clock on a Nasdaq listing.
• NourishFour priced rounds, a reported $1.75 billion valuation and zero SEC filings. What the numbers in the Nourish announcements do and do not reconcile.
• Numerion LabsFour SEC filings under one registrant record $238.6 million sold from 2018 to 2026, through a rename from Atomwise and shrinking offering sizes.
• NurxNurx raised about $113 million and filed no Form D. The merger figure appears only in Thirty Madison's March 2022 filing. The numbers, read closely.
• Ochre BioWhat the Form D filings and Companies House accounts show about Ochre Bio: two 2021 syndicate vehicles, partnership cash, and no Series B.
• One CodexOne Codex has no Form D on record. What it does have is an audited $83,391,000 purchase price and a $19.8 million loss when Invitae sold it back.
• OnederfulNo Form D on record. About $120,000 in disclosed outside capital, a two person team at exit, and an undisclosed sale to Vyne Dental in 2021.
• OpenBiomeA nonprofit with no cap table and no Form D. Twelve Form 990 filings show $45.4 million of revenue, a 2019 peak and a loss making 2024.
• OpentronsOpentrons filed $303.4M sold across eight Form D notices, including $209M in 2021 led by SoftBank, then a 2025 round with only two investors.
• OpheliaThree Form D filings account for $68.36 million of Ophelia equity from 2020 to 2021, matching the announced total. Nothing has been filed since Decemb
• Orange Health LabsIron Pillar led a Rs 277 crore Series C in June 2026 at a reported Rs 1,950 crore post money. The FY26 accounts show Rs 138.6 crore of revenue and a w
• Origami TherapeuticsTen years old with $1.11M in NIH SBIR awards, $500K of reported equity, no Form D on file, and a January 2026 Ipsen option of undisclosed value.
• OsmindOsmind reports $57 million raised through a 2022 Series B. Every Form D that names the company was filed by a third party investment vehicle, not by O
• OtoOto Health raised $3,287,759 from 15 investors in July 2022 and has filed nothing with the SEC since. What the UK and US records actually show.
• Pair TeamTwo Form D filings show $20.18 million sold against a reported $30 million raised. The arithmetic behind Pair Team's 2023 Series A and its Medicaid re
• PapaEvery Papa Form D from 2017 to 2021, the $42.5 million the Series D left open, the SPV that followed, and why nothing has been filed since then.
• Parallel BioParallel Bio reports nearly $30 million raised, yet has never filed a Form D. The only SEC record is two syndicate vehicles holding $377,000.
• Pardes BiosciencesOne Form D, a $257.5M de-SPAC, and a $2.13 per share take-private by Foresite that matched net cash almost exactly. The filings, with the arithmetic s
• PelagoFour Form D filings under Digital Therapeutics, Inc. record $123.6 million sold. Read against the announced rounds, the board and a Sydecar SPV.
• Perception BiosystemsOne accelerator check, zero SEC filings, zero federal grants, and an out of business marker dated February 2022. The whole capital record, read closel
• Perceptive TechnologiesThirty million dollars reported raised, a $15M Series A, $1.71M of NIH grant money, and no Form D on file with the SEC. The arithmetic, step by step.
• Perlara PBCAbout $10 million raised before the 2019 wind down, $4.94 million recorded on two Form D filings, and $1.71 million of NIH money running through 2027.
• Persephone BiosciencesA $15M seed announced in 2022 with no matching SEC filing, one 2021 Form D for $317,000, and an oncology study suspended for lack of funding.
• Persist AIPersist AI announced $16 million across two rounds. Its only SEC filing reports more sold than the seed round was later announced at, and no Series A
• PharosPharos reported a $5 million seed led by Felicis in October 2024. No Form D exists, no round since, and five namesakes muddy every record search.
• PhoenixOne disclosed round of CAD 50 million mixing equity and venture debt, a federal corporate registry entry, and no securities filing to read.
• Pine Park HealthPine Park Health reported $44 million across three rounds and filed nothing with the SEC. Rounds, valuations, CMS enrollment records and commercial si
• PipeBioWhat the Danish company register and three databases show about PipeBio capital, losses, receivables and the undisclosed Benchling price.
• PiramidalPiramidal has one disclosed round, a $6 million seed from August 2024, no SEC Form D on record and no federal grant money. What the gaps say.
• Pirouette PharmaFive Form D filings, two Wefunder campaigns, $479,080 from NIH, and a board roster that keeps changing. The arithmetic behind Pirouette Pharma.
• PNOEPNOE reports about $10.7 million raised, but only one 2016 Form D sits on EDGAR, filed under the name ENDO Medical, Inc. for $440,000 sold.
• PostEraPostEra filed one Form D in seven years: $26.05M sold from 21 investors. Partner cash, not venture money, has funded the business since 2022.
• PreDxion BioPreDxion Bio raised a Y Combinator seed and an NIH STTR award. SEC EDGAR holds no Form D. What the capital record shows and what it leaves out.
• Probably GeneticOne Form D, filed as Aiwa Health, Inc., covers the only priced round on record for Probably Genetic: $10,719,968 sold to 21 accredited investors in 20
• Promakhos TherapeuticsPromakhos raised $2,246,500 from 25 investors in a single 2022 Form D. Since then the money on record has been NIH, state and foundation grants.
• QuartzyThree Form D filings, 30 investors and $27.47 million sold through 2019, then a $23 million lender financing in April 2026 with no Form D.
• QventusFour rounds and $200 million reported, including $20 million of venture debt, with no Form D on file. What the Qventus capital record does and does no
• RarebirdRarebird sold $9.03 million across five Form D notices from 2023 to 2024, added $1.76M in NSF grants, and has filed nothing with the SEC since.
• Rebellyous FoodsFour Form D notices under Seattle Food Tech, Inc., two single-company SPVs, no federal grants, and a 2023 release that understates the filing.
• RecoverRecover has $125,000 in disclosed equity and no Form D on file. The dollar figures that exist sit in California county contracts and state certificati
• Redcliffe LabsOne Form D shows $46,933,880 sold to 15 investors against a $61 million announcement. The capital record for Redcliffe Labs, read closely.
• ReframeReframe filed a single Form D in 2022 reporting $17.45 million sold to 31 investors, including converted SAFEs. Reported totals since then are higher.
• Rejuvenation TechnologiesOne $10.6M seed led by Khosla Ventures, nine NIH award records totaling $7.6M, and not a single Form D notice in SEC EDGAR as of September 2026.
• Reliance HealthTwo Form D filings lodged the same day account for $48,267,398. Nine investors in the Series B, and nothing filed since February 2022.
• Remedial HealthPre-seed to Series A for Nigeria's Remedial Health, the $80,000 Gaingels vehicle that filed first, and the unnamed lenders behind the debt.
• Reshape BiotechReshape Biotech raised $29.1M across three rounds with no SEC Form D. The Danish register shows equity, losses and the capital that arrived in tranche
• Rev GenomicsRev Genomics sold $1,495,360 of a $2,000,000 Regulation D round to 36 investors in 2019 and has filed nothing since. Reading the record.
• Reverie LabsNo Form D, no registered trial, and a $2.4M stock sale to Ginkgo Bioworks against more than $32M raised. Reading the filings on Reverie Labs.
• Revolve SurgicalNo Form D, no EDGAR entity, and three data providers reporting between $125K and $244K raised. What the FDA and Health Canada records show instead.
• Ribbon HealthRibbon Health raised $15.5M on the SEC record and reported $55M in total. The Series B never produced a Form D. H1 bought the company in December 2024
• ScanbaseThe only Form D on record for Scanbase was filed by a syndicate vehicle that sold $321,426 to 110 investors. What the filing shows, with the arithmeti
• Scanwell HealthScanwell Health raised $3.5 million, took $1.6 million from the NIH, filed no Form D, and sold to BD in 2021 at a price never broken out.
• Science ExchangeFive announced rounds totaling $78.5 million, a 2024 buyout by Waud Capital, and zero Regulation D notices on file with the SEC.
• SegmedSegmed announced a $10.4M Series A in 2024. Its only SEC Form D predates it by 22 months and records nothing sold. Reading the filings behind the rele
• Selera MedicalOne reported $500,000 seed round, no SEC Form D, no federal grants, and a registered heart failure trial withdrawn before it enrolled a single patient
• Sensible BiotechnologiesTwo Form D notices covering $15.35 million sold, a pre-seed announcement larger than any filing, and Slovak accounts showing what the business earns.
• Sepsis ScoutSeven years of accelerator cheques and one NIH grant, no SEC Form D, and an October 2024 acquisition by Cytovale. The public totals disagree widely.
• Sequence BioAnnounced rounds, the Venture NL and DCVC investors, the missing securities filings, and the tiered royalty Sequence Bio owes its province.
• Serif HealthSerif Health raised $2.02M in 2022 and $5.65M in 2026 per SEC Form D. What the filings disclose that the press releases did not say.
• SFA TherapeuticsTwo announced rounds totaling $8.5 million, a company-reported $250 million valuation, and no Regulation D notice on file with the SEC.
• ShasqiAbout $68M of disclosed equity, $10.2M of NCI grants, no Regulation D notice ever filed, and no announced round since November 2021.
• Shift LabsShift Labs sold $1.22 million of equity on record in 2015 and took $856,176 in federal awards. The filings stop there. Here is what they show.
• ShimmerShimmer has reported $3.5 million across two seed rounds since 2022 and has filed no Form D. What the public record does and does not show.
• Shiok MeatsWhat Shiok Meats actually raised, what the Singapore registry and the LSE filing confirm, and what the share-for-share UMAMI Bioworks merger left behi
• ShiruShiru reports $36 million raised, yet the only Form D naming it came from a Gaingels angel vehicle. The filings, the arithmetic and the gaps.
• SimplyInsuredThree announced rounds, all before July 2015, no SEC filing of any kind, and a lost QuickBooks channel. What the record shows about the capital.
• SiPhox HealthFive Form D filings, two single-company SPVs and a Massachusetts grant, set against the $32 million SiPhox Health has reported raising since 2020.
• Sixfold BioscienceOne 2.27 million dollar Form D, 1.73 million pounds of Innovate UK grant offers, and filed accounts showing cash and headcount falling hard through 20
• Sleep ResetSimple Habit filed a single Form D in 2018 reporting $12.88M sold to 40 investors. Nothing since. What the record shows about Sleep Reset capital.
• Sohar HealthSohar Health announced a $3.8 million seed in March 2025. No Form D is on file with the SEC, and three published accounts name three different syndica
• SolugenFour Solugen Form D filings report $425.9 million sold from 2018 to 2021, plus a $213.6 million DOE loan guarantee committed but not shown to close.
• SpectSpect disclosed under $6 million across nine years. One 2017 Form D, a 2021 seed round with no Regulation D notice, and a foundation check.
• Spero FoodsA single 2020 Form D, a company claim of $20 million raised, and an all cash sale in 2023 to a buyer that itself unraveled within a year.
• Spiral GeneticsFour Form D filings account for $3.66 million from 2012 to 2016: a $3.2M equity round, a bridge amended three times, and nothing since.
• Spire HealthTwo Form D filings, a Gilde-led round, a growth raise that never closed, and a stock-for-stock sale to Wellinks. The Spire Health capital record.
• Standard CyborgWhat the record shows on Standard Cyborg: one reported seed round, four aggregators that disagree, no SEC filing, and an undisclosed asset sale to Oss
• Stellar SleepA $6 million seed, a $100,000 state grant that paid for the only registered study, and not one filing with the SEC. Reading a record that is mostly ab
• Synapsica HealthcareA $4.2M Series A in 2021, no Form D anywhere in EDGAR, and an Indian registry trail that stops at FY2021. The filings on Synapsica Healthcare, read cl
• SynapticureOne Form D reports $40,145,500 sold to 51 investors, filed weeks before the Series A news, plus $5.18M in NIH awards and no filing since 2024.
• SynviviaSynvivia has $3.05 million in NIH and NSF awards on record and a single SEC Form D for $54,096 sold to one investor in December 2023.
• Syrona HealthNo Form D, no charges, eight years of micro-entity accounts. What the Companies House and UKRI record shows about Syrona Health capital.
• Talus BioTalus Bio announced $11.2M in 2024, but the Form D shows $9.42M sold to 11 investors, alongside $6.43M of federal grants. The arithmetic, line by line
• Tambua HealthNo SEC Form D exists for Tambua Health. Reported seed checks from 2019 and 2020 total more than an aggregator's headline funding figure.
• TAXA BiotechnologiesTAXA raised $484,013 on Kickstarter and $309,807 via Regulation Crowdfunding on Wefunder. SEC filings show no Form D and a 2017 shutdown.
• TetraScienceTwo SEC notices account for $66.0 million sold. The announced Series B was larger than the filing, and the February 2026 raise was never announced.
• The Human Diagnosis ProjectOne Form D in thirteen years, $2.8 million sold to 15 investors in 2013, and a charity whose reported revenue fell from $1.0 million to $56,693.
• Tradewind BioScienceEight years in, the largest documented check is a $405,552 NIH STTR award and the SEC has no registrant under the company name. The full capital recor
• TranscripticEvery Form D on record for Transcriptic and Strateos, the $16.5M merger round, the $56.1M Series B with no filing, and what the gaps show.
• Trestle BiotherapeuticsNo Form D, about $1.1M on the record and a federal prize that is most of it. Reading the capital picture of a preclinical kidney company.
• Trexo RoboticsThree Form D filings totalling $927,500 against a company figure above $5 million, and nothing filed since July 2021. What the SEC record shows.
• TriomicsTriomics raised a $22M Series B in May 2026. SEC records show a single 2023 Form D, $13.75M sold to 10 investors, and no notice for the newer round.
• TrueClaimAbout $2.1 million reported into TrueClaim in 2024, no Form D on EDGAR, and two state TPA registry entries. What the public record does and does not c
• TruepillTruepill sold $307.5 million across four Form D filings, peaked at a $1.6 billion valuation, and was acquired for $525 million with $25 million in cas
• Tuli HealthNo Form D, one statement of capital since 2021, and a Morgan Stanley accelerator cheque. What the Companies House record does and does not show.
• Tuva HealthTuva Health reports $6 million raised across a 2024 seed round and a health system check, with no Regulation D notice anywhere in SEC EDGAR.
• TYBR HealthFour Form D notices trace TYBR Health from a $710,000 seed in 2020 to a $30 million Series A in 2026, with $14.4 million sold when it filed.
• UroDev MedicalThree Form D filings, a 286 day late first notice, and federal grants larger than the venture money. What the SEC and award records show about UroDev
• VedaBioOver $65 million reported raised since 2021, one lead investor across both rounds, Siemens Healthineers added in 2025, and no Form D on file with the
• Veera HealthVeera Health announced a $3.0M seed in July 2021 and has no SEC filing. MCA records show where the share capital, the revenue and the headcount actual
• Vena MedicalVena Medical files nothing with the SEC. What the Ontario grant, the Health Canada licences and the FDA clearances reveal about its capital picture.
• Vena VitalsEvery hard number for Vena Vitals is an NSF or NIH grant. No Form D exists, and four funding trackers disagree about the equity by a factor of five.
• VenoStentSix Form D notices, $29.2 million sold, $7.4 million of federal awards, and a $10 million debt round in April 2026 that no press release mentions.
• Verge GenomicsTwo announced rounds totaling $130 million, a single Form D $13M short of the headline, an unfiled Series C, and a lender mark down 58 percent in one
• VerifiableVerifiable funding profile: $47M raised across seed, Series A and Series B, with SEC Form D filings that reached EDGAR before the press.
• VetProntoThree Regulation Crowdfunding filings, $362,718 from 636 investors at about $570 each, a revenue line reported as zero, and an exit below the buyer's
• Viosera TherapeuticsA single Form D for 12.78 million dollars from 44 investors, filed two days after the round closed, and nothing on file before or since.
• Vitable HealthThree announced rounds totaling $24.8 million, a $25 million company figure frozen since 2024, one acquisition, and no Form D on file with the SEC.
• Volt HealthVolt Health has $120,000 of capital on record from Y Combinator, no Regulation D filing with the SEC, and a private secondary trade logged in March 20
• Volta LabsTwo Form D offerings record $37.7 million sold. One was announced below its filed total, the other was never announced at all.
• Volumetric BiotechnologiesNo Form D of its own, $323,000 through four outside syndicates, then $40.2M at closing and an earnout of up to $355.0 million that paid nothing.
• Voyage BiomedicalNo Form D, no venture round, $150K on record and an undisclosed sale to Penumbra. Reading a stroke cooling startup by what it never filed.
• WatsiNo Form D, no cap table. Watsi is a 501(c)(3), and its IRS Form 990 filings show $17.9 million in patient grants paid and a 2024 deficit.
• WyndlyOne announced $2M round, zero Form D filings, and a quarterly valuation mark published only because a registered fund holds the SAFE.
• X-ZELLX-ZELL closed a US$4 million Seed+ in October 2020 after 28 months. No SEC Form D exists, and nothing has been announced in the six years since.
• XGenomesNo Form D has ever been filed for XGenomes. The documented capital is $2.04 million of NIH Phase I grants, and four databases disagree on the rest.
• Yemaachi BiotechnologyA $3M seed, a $1M Gates fellowship, a share of a $25M cancer award and zero Form D filings. Reading the Yemaachi capital record.
• YourChoice TherapeuticsOne $15M Series A, no Form D of its own, and an outside SPV that raised $1.03M from 40 investors in 2025. What the filings show and omit.
• ZBioticsTwo Regulation D offerings totalling $28.1 million, four single-company vehicles, and an announced Series A that named about half the filed amount.
• ZealthAntler, Y Combinator and two undisclosed rounds total about $230,000. The only SEC Form D filed under the name Zealth belongs to another company.
• Zeit MedicalZeit Medical raised $2 million in October 2021 and has disclosed nothing since. No Form D exists, and the only SEC record naming it is a proxy.
• ZenflowZenflow has $75.3 million of equity on record across three rounds. The Series C Form D reports $4.6 million less than the announcement did.
• ZergoA reported $2.6 million seed, zero SEC filings, and three data services carrying three different totals. What the Zergo and SannTek Labs record shows.
• Zeta SurgicalThe SEC record covers about 59 percent of the capital Zeta Surgical has announced, and no Form D has reached EDGAR since November 2023.
• zPREDICTANo Form D, about $220,000 of private funding on record, and a $10,015,941 cash acquisition that the buyer impaired in full within thirteen months.